Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

UC San Diego and Allele together in ARPA-H research project
Date 16 January 2026

UC San Diego and Allele together in ARPA-H research project

Introduction Allele Biotechnology Company, known for its regenerative medicine and modern cell therapy, entered the competitive healthcare sector in 1999. The company is a face of Contract Developmen...

AbbVie's smart deal to avoid tariff storm in the near future
Date 16 January 2026

AbbVie's smart deal to avoid tariff storm in the near future

Introduction AbbVie biopharmaceutical company,’ hold its ground from the existence of Abbott Laboratories in 2013. The company is known for its innovative medicines for crucial diseases such as...

Sentynl and Fortress 'COMEBACK' with its Menkes disease therapy
Date 16 January 2026

Sentynl and Fortress 'COMEBACK' with its Menkes disease therapy

Introduction Sentynl Therapeutics, a U.S. biopharmaceutical company with its exclusive Zydus Lifesciences, centralising its aim at first place for establishing and introducing specialised, effective ...

SGT-212 received Orphan Drug Designation to treat Friedreich's Ataxia
Date 15 January 2026

SGT-212 received Orphan Drug Designation to treat Friedreich's Ataxia

Introduction Solid Biosciences Inc. is a leading precision genetic medicine company concentrating on gene therapies for cardiac disease, rare neuromuscular diseases, and mainly for Friedreich’s...

EMD Serono received FDA approval for its NDA, curing Tenosynovial Giant Cell Tumor
Date 15 January 2026

EMD Serono received FDA approval for its NDA, curing Tenosynovial Giant Cell Tumor

Introduction EMD Serono, a strong business of Merck KGaA, is a polished tech and global science company known for the creative and unique treatment for complicated diseases such as cancer, infertilit...

Theralase and Ferring entered into a valuable deal to magnify the dual impact therapy in Bladder Cancer
Date 15 January 2026

Theralase and Ferring entered into a valuable deal to magnify the dual impact therapy in Bladder Cancer

Introduction Ferring Pharmaceuticals, a leading research centric specialty biopharmaceutical entity known for establishing unique therapies for maternal health and reproductive drugs. Since 1950, the...

Novartis confidence and SciNeuro's excellence to heal the Alzheimer's patient group
Date 15 January 2026

Novartis confidence and SciNeuro's excellence to heal the Alzheimer's patient group

Introduction The Switzerland-based, science-centric, and leading pharmaceutical company Novartis, along with its innovative treatments, has helped address crucial areas of disease. The company found ...

The millions of Life Sciences Fund speaks unity of three healthcare enthusiasts
Date 14 January 2026

The millions of Life Sciences Fund speaks unity of three healthcare enthusiasts

Introductions The BioNTech SE is a German-based biotechnology company that has new technologies to introduce to its leading investigative, effective therapies for infectious diseases and cancer. The ...

Taiwan's Healthy Taiwan Sprout Project calls for smart healthcare
Date 14 January 2026

Taiwan's Healthy Taiwan Sprout Project calls for smart healthcare

Taiwan’s healthcare sector Taiwan’s healthcare sector is crowned for its global, single-payer National Health Insurance (NHI) system. The region has successfully served robust, affordable...

PAI's smart business move to skyrocket US injectable drug creation
Date 14 January 2026

PAI's smart business move to skyrocket US injectable drug creation

Introduction PAI Pharma is known for developing, processing and circulating the generic oral liquids, packed in bottles and ready to dose (RTD) in the US region. The company holds a wide range of gen...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.